Table of Contents
TogglePathology of the Female Genital Tract (Part 1: Vulva, Vagina, & Cervix)
I. Foundational Concepts: Anatomy & Epithelium
Before studying the pathology of the female genital tract, it is absolutely crucial to understand the normal anatomy and the specific types of epithelial tissues that line these organs. The type of epithelium directly dictates the type of infections that can take hold and the type of cancers that will develop.
The female reproductive tract is divided into the external genitalia (Vulva) and internal organs (Vagina, Cervix, Uterus, Fallopian Tubes, and Ovaries).
- The Vulva: The external genitalia. It includes hair-bearing skin (the labia majora) and non-hair-bearing mucosa (the labia minora).
- The Vagina: Lined by stratified squamous non-keratinized epithelium. Designed to withstand friction.
- The Ectocervix: The part of the cervix protruding into the vagina. Lined by the same squamous epithelium as the vagina.
- The Endocervix: The inner canal of the cervix. Lined by a single layer of tall, mucus-secreting columnar epithelium.
Exam Concept: Cancers of the vulva, vagina, and ectocervix will predominantly be Squamous Cell Carcinomas (SCC), whereas cancers of the endocervix and endometrium will predominantly be Adenocarcinomas (glandular cancers).
II. Pathology of the Vulva
Disorders of the vulva are most frequently inflammatory, rendering them highly uncomfortable (due to intense itching and pain) rather than serious. However, malignant tumors of the vulva, though rare, are life-threatening.
1. Vulvar Glandular Anatomy & Pathology
The vulva contains specialized glands that provide lubrication and immune defense.
- Bartholin Glands: The major vestibular glands. They have a tubuloalveolar structure made of acini composed of mucus-secreting columnar cells. Their excretory ducts are lined with transitional epithelium.
- Skene (Periurethral) Glands: Analogous to the male prostate gland. They are lined by pseudostratified mucus-secreting columnar epithelium that merges into transitional epithelium, and finally into stratified squamous epithelium at the vestibule.
- Minor Vestibular Glands: Simple tubular glands lined by mucus-secreting columnar epithelium.
- Lymphatic Drainage: Most vulvar lymph vessels drain to the superficial inguinal nodes. However, the clitoris (which contains erectile tissue similar to the corpora cavernosa of the penis) drains directly into the deep chain nodes.
Infection of the Bartholin gland produces acute inflammation. Because the excretory duct is narrow, the inflammatory process often leads to severe obstruction.
- Formation: The continued secretion of mucus behind the blocked duct causes a painful dilation known as a Bartholin Cyst. If secondary bacterial infection occurs, it rapidly becomes a Bartholin Abscess.
- Morphology: They are relatively common at all ages. They are lined by transitional or squamous epithelium. They can grow large (up to 3 to 5 cm in diameter) and produce immense local pain and discomfort.
- Treatment: They are either excised or opened permanently to drain via a surgical procedure called Marsupialization.
2. Vulvitis (Inflammation of the Vulva)
One of the most common causes of vulvitis is reactive inflammation in response to an exogenous stimulus.
- Reactive Causes: Can be triggered by an irritant (contact irritant dermatitis, e.g., harsh soaps) or an allergen (contact allergic dermatitis). Scratching-induced trauma secondary to associated intense "itching" (pruritus) heavily exacerbates the primary condition, leading to excoriation.
- Infectious Causes: Often sexually transmitted.
- HPV (Human Papillomavirus): Causative agent of condyloma acuminatum, Vulvar Intraepithelial Neoplasia (VIN), and one specific type of vulvar squamous cell carcinoma.
- HSV-1 or HSV-2: The agents of genital herpes (painful vesicles).
- Neisseria gonorrhoeae: A cause of suppurative (pus-forming) infection of the vulvovaginal glands.
- Treponema pallidum: Causes the primary chancre (painless ulcer) of syphilis at vulvar sites of inoculation.
- Candida albicans: A major cause of vulvitis, characterized by thick white discharge, but it is not sexually transmitted.
3. Non-Neoplastic Epithelial Disorders
Clinically, many vulvar lesions present as Leukoplakia. Leukoplakia is purely a descriptive clinical term for an opaque, white, plaque-like epithelial thickening that may produce pruritus and scaling. It is not a diagnosis. Causes of leukoplakia range from benign inflammatory dermatoses (Psoriasis, chronic dermatitis), Lichen Sclerosus, to neoplasias like VIN, Paget disease, and invasive carcinoma.
Lichen Sclerosus
- Clinical Presentation: Presents as smooth, white plaques or macules that enlarge and coalesce over time, producing a surface that perfectly resembles porcelain or parchment paper. When the entire vulva is affected, the labia become severely atrophic and stiffened, and the vaginal orifice painfully constricts.
- Histology: Characterized by dramatic thinning of the epidermis, degeneration of the basal epithelial cells, excessive keratinization (hyperkeratosis), sclerotic (fibrotic) changes of the superficial dermis, and a characteristic band-like lymphocytic infiltrate in the underlying dermis.
- Pathogenesis: An autoimmune etiology is strongly proposed. This is supported by the presence of activated T-cells in the subepithelial infiltrate and an increased frequency of concurrent autoimmune disorders in affected women.
- Clinical Risk: Occurs in all age groups but most commonly affects postmenopausal women and prepubertal girls. While essentially benign, 1% to 5% of women with symptomatic lichen sclerosus develop HPV-negative squamous cell carcinoma of the vulva.
4. Benign Tumors of the Vulva (Condylomas)
Condyloma is the general term for any warty lesion of the vulva. There are two distinct forms you must differentiate for exams:
- Condylomata Lata: Not commonly seen today. These are flat, minimally elevated lesions that occur in Secondary Syphilis (Treponema pallidum).
- Condylomata Acuminata: Very common. These are exophytic, papillary, distinctly elevated, or somewhat flat and rugose lesions. They are caused by low-risk HPV types 6 and 11. They are rarely solitary; they are frequently multifocal and involve the vulvar, perineal, and perianal regions, as well as the vagina.
Histology of Condyloma Acuminatum: On examination, they consist of papillary, exophytic, tree-like cores of stroma covered by thickened squamous epithelium (acanthosis) and hyperkeratosis. The hallmark sign is Koilocytic Atypia—a viral cytopathic effect characterized by nuclear enlargement, hyperchromasia (dark nuclei), and a distinct cytoplasmic perinuclear halo. Note: Condylomata acuminata are strictly benign and are NOT precancerous lesions. HPV vaccines prevent them.
5. Vulvar Intraepithelial Neoplasia (VIN) & Vulvar Carcinoma
Vulvar carcinoma represents about 3% of all female genital tract cancers, occurring mostly in women older than age 60. In terms of etiology, pathogenesis, and histology, vulvar squamous cell carcinomas are strictly divided into two distinct groups.
Etiology: Caused by high-risk HPVs (most commonly HPV-16).
- Prevalence & Demographics: Accounts for 30% of invasive cases. Tends to occur in relatively younger women (average peak in 6th decade / 60 years of age). Risk factors include early age at first intercourse, multiple partners, and immunosuppression.
- Precursor Lesion: High-Grade Squamous Intraepithelial Lesion (HSIL), formerly known as classic VIN or Bowen disease. Usually hyperkeratotic or pigmented.
- Histology: Basaloid carcinoma consists of nests and cords of small, tightly packed cells lacking maturation, resembling the basal layer. May have central necrosis. Warty carcinoma has exophytic, papillary architecture with prominent koilocytic atypia.
- Prognosis: Generally less aggressive. Nonsurgical treatments (Imiquimod/antivirals) are somewhat effective for the precursor VIN.
Etiology: Unrelated to HPV. Develops from chronic epithelial irritation.
- Prevalence & Demographics: The most common form (70% of invasive cases). Occurs in older women (average peak in 8th decade / 75 years of age).
- Precursor Lesion: Differentiated Vulvar Intraepithelial Neoplasia (dVIN). It is almost always found adjacent to long-standing Lichen Sclerosus or squamous cell hyperplasia.
- Pathogenesis: Chronic irritation drives a gradual evolution to malignancy via the acquisition of somatic driver mutations. A high frequency of TP53 mutations (a tumor suppressor gene) is reported in dVIN.
- Histology & Prognosis: Well-differentiated tumors that elaborate dense keratin pearls. Prognosis is worse, with significantly higher recurrence rates and mortality compared to the HPV pathway.
Prognosis of Vulvar Carcinoma
The overall 5-year survival rate is 50-75%. Prognosis is dictated by:
- Stage & Nodal Status: The absolute most important prognostic determinator. If lymph nodes are involved, the presence of extracapsular nodal spread and large metastatic focus size are very poor indicators.
- Tumor Metrics: Infiltrative margins, deep depth of invasion, and large tumor diameter. Microinvasive carcinoma refers to tumors where the depth of penetration is strictly less than 5mm.
- Vascular Invasion & Stromal Response: Blood vessel invasion and a prominent fibromyxoid stromal response correlate with extensive lymph node metastases.
- Molecular Markers: Diffuse immunohistochemical overexpression of the P53 protein is associated with severely decreased survival.
6. Extramammary Paget Disease of the Vulva
Paget disease is an intraepidermal proliferation of malignant epithelial cells. While Paget disease of the breast nipple is virtually always associated with an underlying invasive ductal carcinoma, only a minority of cases of vulvar (extramammary) Paget disease have an underlying tumor. It is a vulvar adenocarcinoma of uncertain histogenesis, most likely arising directly from epidermal progenitor cells.
- Gross Appearance: Appears as a fiery red, erythematous, scaly, crusted, elevated plaque on the labia or perineal skin of adult and elderly patients. The disease is often very extensive.
- Microscopy: Large tumor cells with abundant pale, finely granular, pale-pink cytoplasm and occasional cytoplasmic vacuoles are seen infiltrating the epidermis, singly and in groups. A clear cleft often develops between the malignant cells and the normal overlying keratinocytes.
- Crucial Diagnostics (Exam High-Yield): Melanin granules may occasionally be seen inside these tumor cells, which can mimic melanoma. To definitively distinguish Paget disease from Vulvar Melanoma, use specific stains:
- Paget Disease: Positive for Mucin (detected by PAS stain), Pankeratin, Cytokeratin 7 (CK7), EMA, CEA, and GCDFP-15 (a strict marker of apocrine gland differentiation). S100 is positive in about 1/3 of cases, but HMB-45 is always negative.
- Melanoma: S100 positive, HMB-45 positive, but PAS/Mucin and Keratin negative.
III. Pathology of the Vagina
The vagina is remarkably resilient, and primary diseases here are rare. Most pathology involves secondary extension from the cervix or vulva.
1. Vaginitis
A common, usually transient condition of little systemic consequence, but associated with the highly uncomfortable production of vaginal discharge (leukorrhea).
- Etiology: A large variety of organisms (bacteria, fungi, parasites) are implicated. Many are normal commensal flora that only become pathogenic opportunists during states of altered immunity or flora disruption, such as diabetes, systemic antibiotic therapy, immunodeficiency, pregnancy, or recent abortion.
- Common Offenders: Candida albicans (thick, white, cottage-cheese discharge) and Trichomonas vaginalis (frothy, yellow-green discharge).
2. Malignant Neoplasms of the Vagina
Primary Squamous Cell Carcinoma (SCC) of the vagina is an extremely uncommon cancer.
- Pathogenesis: It usually occurs in women older than 60 years. The risk factors are identical to those of cervical carcinoma (early intercourse, multiple partners, smoking).
- Precursor: Vaginal Intraepithelial Neoplasia (VAIN) is the precursor lesion, which is nearly always associated with high-risk HPV infection.
- Invasive Disease: Invasive SCC of the vagina contains HPV DNA in more than 50% of cases, deriving directly from HPV-positive VAIN.
IV. Pathology of the Cervix
While the cervix mostly suffers from banal inflammation (Cervicitis), it is famously the site of one of the most common and deadly cancers in women worldwide. To understand cervical cancer, you must first master the Transformation Zone.
During embryologic development, the columnar mucus-secreting epithelium of the endocervix strictly meets the squamous epithelium of the ectocervix at a point called the squamocolumnar junction (SCJ), located at the cervical os.
With the onset of puberty and hormonal changes, the cervix grows, causing the SCJ to undergo eversion (rolling outward). This physically exposes the delicate columnar epithelium of the endocervix to the harsh, acidic environment of the vagina. To survive the acid, these exposed columnar cells undergo Squamous Metaplasia (changing into tough, immature squamous cells). This entire geographic area of metaplastic change is called the Transformation Zone (TZ). Because the cells here are rapidly dividing and immature, they are highly vulnerable to viral DNA integration. The TZ is where almost all cervical tumors arise.
1. Cervicitis (Inflammatory Lesions)
A very common condition in adult females, often presenting with purulent vaginal discharge. It affects preferentially the squamocolumnar junction and endocervix. It causes hyperemia, edema, fibrosis, and inflammatory metaplastic changes.
- Non-Infectious/Endogenous: Caused by the overgrowth of normal vaginal flora (incidental aerobes/anaerobes, Strep, Staph, Enterococci, E. coli, and Candida).
- Infectious (Sexually Transmitted): The most important causes include Chlamydia trachomatis, Neisseria gonorrhoeae, Ureaplasma urealyticum, Trichomonas vaginalis, HSV-2, and certain types of HPV.
2. Neoplasia of the Cervix (The HPV Pathway)
Virtually all cervical precursor lesions and cancers are caused by persistent infection with oncogenic (high-risk) strains of HPV, particularly HPV-16 and HPV-18 (which account for 70% of cases).
Most HPV infections are actually transient and are successfully eliminated within months by the host's immune system. However, a small subset of infections persists. The virus colonizes the immature squamous cells of the Transformation Zone using two highly lethal viral oncoproteins:
- Viral Protein E6: Binds to and destroys p53 (the "guardian of the genome," a tumor suppressor that normally induces apoptosis in genetically damaged cells).
- Viral Protein E7: Binds to and inactivates RB (Retinoblastoma protein) (a potent tumor suppressor that normally halts the cell cycle).
Without p53 and RB, the squamous cells divide uncontrollably as they mature, accumulating massive amounts of somatically acquired mutations.
Co-Risk Factors: Early age at first intercourse, multiple sexual partners, a male partner with multiple previous partners, cigarette smoking, and coinfection with HIV or other STIs. Immune and hormonal status play a major role in allowing the virus to persist.
3. Squamous Intraepithelial Lesion (SIL / CIN)
HPV-related carcinogenesis begins with a precancerous epithelial change termed Squamous Intraepithelial Lesion (SIL), also historically known as Cervical Intraepithelial Neoplasia (CIN). SIL usually precedes overt cancer by many years, sometimes decades. (SIL incidence peaks at age 30, whereas invasive carcinoma peaks at age 45).
The terminology has evolved into a two-tiered system reflecting biology and patient management:
| Old Dysplasia Term | Old CIN Term | Current SIL Classification | Morphological Description |
|---|---|---|---|
| Mild dysplasia | CIN I | Low-grade SIL (LSIL) | Dysplastic changes restricted to the lower 1/3 of the squamous epithelium. Prominent koilocytotic change in the superficial layers. Associated with productive HPV infection. Most LSILs naturally regress; very few progress. |
| Moderate dysplasia | CIN II | High-grade SIL (HSIL) | Dysplasia extends to the middle 1/3. Shows variation in cell/nuclear size, chromatin heterogeneity, and abnormal mitoses. Arrested maturation. Superficial cells still show some differentiation and occasional koilocytes. |
| Severe dysplasia / Carcinoma in situ | CIN III | High-grade SIL (HSIL) | Almost complete loss of differentiation extending through all layers (full thickness) of the epithelium. Severe nuclear atypia, disorderly orientation, abnormal mitoses. Koilocytotic change is usually ABSENT in CIN III. |
The Pap Smear Rationale: As the grade of the lesion increases (from LSIL to HSIL), the cells lose their ability to mature. A normal superficial cell has a tiny nucleus and massive cytoplasm. In HSIL, the cells scraped off the cervix show a massive, dark nucleus and very little cytoplasm (High Nucleus-to-Cytoplasm ratio). Finding these exfoliated cells early prevents cancer.
4. Invasive Carcinoma of the Cervix
If HSIL is left untreated, it penetrates the basement membrane, becoming invasive carcinoma. The peak incidence is ~45 years of age (10 to 15 years after precursor detection). Genes in the HLA region of chromosome 6 are associated with increased susceptibility to HPV transformation.
- Squamous Cell Carcinoma (75% of cases):
- Gross: May be exophytic (polypoid) or deeply infiltrative. Bulky exophytic tumors that grow out into the vagina are paradoxically less likely to invade surrounding pelvic structures than the flat, infiltrating ones.
- Microscopic: Consists of tongues and nests of malignant squamous cells producing a desmoplastic (fibrous) stromal response. Rises from HSIL. Differentiation ranges from minimal to well-differentiated tumors containing prominent keratin pearls.
- Adenocarcinoma & Adenosquamous Carcinoma (20% of cases): Arises from the columnar cells of the endocervix. Characterized by malignant endocervical glands with large hyperchromatic nuclei and mucin-depleted cytoplasm. Looks much darker than normal glands. Adenosquamous contains mixed glandular and squamous malignant elements.
- Small Cell Neuroendocrine Carcinoma (<5% of cases): Extremely aggressive. Morphologically resembles small cell carcinoma of the lung but differs by being strongly positive for high-risk HPV.
Prognosis of Cervical Carcinoma
Prognosis is strictly related to physical staging parameters (since the anatomy of the pelvis dictates how the cancer kills, usually by invading the ureters and causing renal failure).
- Clinical Stage & Nodal Status: The absolute most important prognostic determinators. Includes the size of the largest involved node and the total number of positive nodes.
- Tumor Metrics: Size/volume of the primary tumor (greatest diameter) and depth of invasion.
- Endometrial Extension: If the cervical cancer grows upward into the endometrium, the survival rate drops by 10%–20%.
- Parametrial & Vascular Involvement: Microscopic invasion into the parametrium (connective tissue alongside the cervix) and blood vessel invasion are extremely poor prognostic signs.
5. Benign Endocervical Polyps
These are benign, sessile (or pedunculated) polypoid masses protruding from the endocervical mucosa, sometimes visibly peaking through the exocervix. They range from 0.5 to 3 cm.
- Morphology: They have a smooth, glistening surface. The core consists of a dense, edematous fibromyxoid stroma containing scattered mononuclear inflammatory cells and small muscular arteries. They are lined by mucus-secreting columnar cells, with underlying cystically dilated glandular spaces.
- Clinical Significance: They occur at any age but are most common around menopause. Superimposed chronic inflammation may lead to squamous metaplasia and surface ulceration. The main clinical issue is that they bleed, mimicking cancer and arousing intense concern, but they have absolutely zero malignant potential.
Part 2: Uterus - Endometrium & Myometrium
I. Foundational Concepts: The Uterine Corpus
Before diving into the specific diseases, we must clearly define the two primary layers of the uterine body (corpus), as pathology behaves entirely differently depending on which layer is affected:
- The Endometrium: The inner lining of the uterus. It is a highly dynamic, hormonally responsive tissue composed of tubular glands supported by a specialized cellular stroma. It thickens and sheds cyclically during menstruation. Diseases here are typically driven by hormonal imbalances (estrogen), infection, or glandular cancers.
- The Myometrium: The thick, outer muscular wall. It is composed of interlacing bundles of smooth muscle. Diseases here are typically structural (like benign smooth muscle tumors) or involve the abnormal invasion of tissue.
II. Inflammatory Lesions of the Uterus
Endometritis (Inflammation of the Endometrium)
Endometritis is classified as acute or chronic depending on the type of inflammatory cells predominating in the tissue.
To diagnose chronic endometritis microscopically, a pathologist must see plasma cells. Why? Because normal endometrial stroma natively contains lymphocytes as part of the normal menstrual cycle. The presence of a stromal lymphoplasmacytic infiltrate (lymphocytes + plasma cells) coexisting with a superficial neutrophilic infiltrate confirms the disease.
- Etiology & Causes:
- Pelvic Inflammatory Disease (PID): Frequently a result of ascending sexually transmitted infections, primarily Neisseria gonorrhoeae or Chlamydia trachomatis. (Chlamydial infections uniquely show prominent lymphoid follicles).
- Tuberculosis: Causes granulomatous endometritis, frequently associated with tuberculous salpingitis (fallopian tube infection) and peritonitis.
- Foreign Bodies & Retained Tissue: The presence of an Intrauterine Device (IUD) or Retained Products of Conception (RPOC) subsequent to a miscarriage or delivery. These retained tissues act as a nidus (breeding ground) for ascending infection by normal vaginal or intestinal tract flora.
- Clinical Presentation: All forms manifest with fever, pelvic/abdominal pain, and menstrual abnormalities.
- Complications: If left untreated, it leads to a significantly increased risk of permanent infertility and ectopic pregnancy (due to scarring of the fallopian tubes). Removal of the offending tissue or foreign body typically results in full resolution.
III. Misplaced Endometrial Tissue
Normally, endometrial glands and stroma are strictly confined to the inner lining of the uterus. When this tissue grows in the wrong place, it causes severe pain and bleeding because it still responds to the monthly hormonal cycle.
1. Adenomyosis ("Internal" Endometriosis)
Adenomyosis is defined as the abnormal presence of endometrial tissue (nests of stroma, glands, or both) deep within the myometrium, interposed between the smooth muscle bundles.
- Morphology: The misplaced endometrial tissue acts as an irritant. It induces reactive hypertrophy and hyperplasia of the surrounding myometrium. This results in an enlarged, globular uterus with a characteristically thickened uterine wall.
- Clinical Signs: Extensive adenomyosis produces heavy menstrual bleeding (menorrhagia), severe cramping (dysmenorrhea), and pelvic pain, particularly just prior to menstruation. It can, and often does, coexist with endometriosis.
2. Endometriosis ("External" Misplacement)
Endometriosis is defined as the presence of functional endometrial glands and stroma in a location outside the uterus. It is incredibly common, seen in as many as 10% of women in their reproductive years, and is responsible for nearly 50% of female infertility cases.
- Common Sites: It is multifocal. It heavily involves pelvic structures including the ovaries, the Pouch of Douglas, uterine ligaments, fallopian tubes, and the rectovaginal septum. Distant/rare sites include the peritoneal cavity, periumbilical tissues, lymph nodes, lungs, and even the heart, skeletal muscle, or bone!
The Four Theories of Pathogenesis
How does uterine tissue end up in the lungs or on the ovaries? Four main theories attempt to explain this:
- The Regurgitation Theory (Currently Favored): Proposes that menstrual blood flows backward (retrograde menstruation) through the fallopian tubes, spilling endometrial cells into the peritoneal cavity where they implant and grow.
- The Metaplastic Theory: Posits that coelomic epithelium (the mesothelium lining the pelvis and abdomen, from which the endometrium originally develops embryologically) undergoes abnormal differentiation (metaplasia) directly into endometrial tissue.
- The Benign Metastases Theory: Holds that endometrial tissue from the uterus can "metastasize" to distant sites (like the lungs or brain) via blood vessels and lymphatic channels.
- The Extrauterine Stem/Progenitor Cell Theory: Proposes that circulating stem/progenitor cells originating from the bone marrow travel to distant sites and differentiate into endometrial tissue.
Molecular Pathogenesis & Treatment Targets
Endometriotic tissue is not just misplaced; it is biologically abnormal. It exhibits vastly increased levels of inflammatory mediators, particularly Prostaglandin E2 (PGE2). Inflammation results from the recruitment and activation of macrophages by factors made by the rogue endometrial stromal cells.
Furthermore, these stromal cells aberrantly produce the enzyme aromatase, leading to the localized, independent production of estrogen. These factors intensely enhance the survival of the tissue in a foreign location. Pharmacological Pearl: This perfectly explains why COX-2 inhibitors (to stop PGE2) and Aromatase inhibitors (to stop local estrogen) are highly effective in treating endometriosis.
Morphology of Endometriosis
- Gross Appearance: The tissue functions normally, meaning it undergoes cyclic bleeding. The old blood organizes into red-brown nodules or implants (varying from microscopic to 1-2 cm). Individual lesions often coalesce to form larger masses.
- Chocolate Cysts: When the ovaries are involved, cyclic bleeding into a closed space forms massive, blood-filled cysts. As the trapped blood ages, it turns a thick, dark brown color, clinically referred to as a "Chocolate Cyst" (Endometrioma).
- Complications: With continuous seepage and organization of blood, widespread fibrosis occurs. This leads to dense adhesions (scar bands) among pelvic structures, the sealing of the tubal fimbriated ends (causing infertility), and severe distortion of the fallopian tubes and ovaries.
- Diagnosis: Requires finding both endometrial glands and stroma at sites external to the endometrium microscopically.
IV. Abnormal Uterine Bleeding (AUB)
AUB is an umbrella term encompassing menorrhagia (profuse/prolonged bleeding), metrorrhagia (irregular bleeding between periods), and postmenopausal bleeding. The cause heavily depends on the age of the patient.
- Organic Causes: Endometrial polyps, leiomyomas (fibroids), endometrial hyperplasia, and endometrial carcinoma.
- Dysfunctional Uterine Bleeding (DUB): This is abnormal bleeding in the absolute absence of an organic uterine lesion.
- The most common cause of DUB is Anovulation (failure to ovulate). Anovulatory cycles result from hormonal imbalances and are most common at the extremes of reproductive life (menarche and perimenopause).
- Causes of Anovulation: Fluctuations in the hypothalamus/pituitary/ovarian axis; Endocrine disorders (thyroid, adrenal, pituitary tumors); Ovarian lesions (Polycystic Ovarian Syndrome - PCOS, or functioning granulosa cell tumors); Generalized metabolic disturbances (obesity, malnutrition).
- Inadequate Luteal Phase: Another cause of DUB stemming from the insufficient production of progesterone by the corpus luteum, leading to premature shedding of the lining.
V. Proliferative Lesions of the Endometrium
1. Endometrial Hyperplasia
Endometrial hyperplasia is an exaggerated proliferation of the endometrium. It is an extremely important precursor to endometrial carcinoma.
Pathogenesis: It is driven by an excess of estrogen relative to progestin. If this unopposed estrogen is sufficiently prolonged, it induces marked hyperplasia. Causes of estrogen excess include:
- Obesity: Peripheral adipose tissue contains aromatase, which converts circulating steroid precursors (androgens) into active estrogens.
- Failure of ovulation: (e.g., perimenopause), leading to a lack of balancing progesterone.
- Polycystic Ovarian Syndrome (PCOS).
- Estrogen-producing ovarian lesions: Granulosa-theca cell tumors.
- Pharmacological: Prolonged administration of estrogenic steroids without counterbalancing progestin.
| Category | Morphology | Risk of Progression to Cancer |
|---|---|---|
| Hyperplasia without Atypia | Characterized by nests of closely packed glands varying in size and shape, but the cells themselves look normal. | Low risk (between 1% and 3%). |
| Hyperplasia with Atypia (EIN) | Also called Endometrial Intraepithelial Neoplasia (EIN). Seen as severe glandular crowding and distinct cellular atypia (abnormal nuclei, loss of polarity). | High risk (20% – 50%). If discovered, the patient must be carefully evaluated/treated for the presence of concurrent cancer. |
2. Endometrial Polyps
Benign, exophytic masses usually ranging from 0.5 to 3 cm. They are sessile and may project far into the uterine cavity. Most common around menopause.
- Morphology: Composed of endometrium that resembles the basalis layer, uniquely containing small, thick-walled muscular arteries. The glands are often cystically dilated.
- Clinical Significance: They frequently cause abnormal uterine bleeding (AUB), mimicking more dangerous conditions. They have negligible malignant potential.
VI. Endometrial Carcinoma
The most common cancer of the female genital tract. It generally appears between the ages of 55 and 65 years and is highly uncommon before age 40. It is broadly divided into two histologically and pathogenically distinct categories.
Frequency: Accounts for 80% of cases.
- Pathogenesis: Arises in association with estrogen excess in the setting of endometrial hyperplasia in perimenopausal women.
- Genetics/Risk Factors: Obesity, Diabetes, Hypertension, Infertility. Early genetic events include mutations in mismatch repair genes (patients with Lynch Syndrome) and the PTEN tumor suppressor gene (patients with Cowden Syndrome are at massive risk).
- Morphology: They closely resemble normal endometrial glands (hence the name). They may be exophytic or infiltrative, showing mucinous, tubal, or squamous differentiation. They frequently invade the myometrium and lymphovascular spaces. Graded 1 to 3 based on loss of glandular differentiation.
Frequency: Accounts for roughly 15% of cases.
- Pathogenesis: Arises in older, postmenopausal women in the setting of endometrial atrophy. It is not associated with unopposed estrogen or hyperplasia.
- Genetics: Nearly all cases have mutations in the TP53 tumor suppressor gene. Mismatch repair and PTEN mutations are rare. Preceded by a lesion called Serous Endometrial Intraepithelial Carcinoma (SEIC).
- Morphology: They grow in small tufts and papillae with marked cytologic atypia. They behave aggressively and are, by definition, strictly High Grade. Immunohistochemistry shows diffuse, strong positive staining for p53.
Other less common types include clear cell carcinoma and mixed Mullerian tumor (carcinosarcoma).
VII. Proliferative Lesions of the Myometrium: Leiomyoma
Leiomyomas are benign tumors that arise from the smooth muscle cells of the myometrium. Because of their hard, firm consistency, they are clinically referred to as Fibroids. They are the most common benign tumor in females, affecting 30% to 50% of women of reproductive age (and are considerably more frequent in black women).
- Genetics & Hormones: Associated with recurrent chromosomal abnormalities (rearrangements of chromosomes 6 and 12). Their growth is heavily stimulated by Estrogens (and possibly oral contraceptives). Consequently, these tumors naturally shrink postmenopausally when estrogen drops.
- Gross Morphology: Typically sharply circumscribed, firm, gray-white masses. They have a highly characteristic whorled cut surface. They occur singly, but much more often present as multiple tumors scattered within the uterus.
- Locations: Intramural (within the muscle), Subserosal (under the outer lining), or Submucosal (protruding into the inner cavity).
- Parasitic Leiomyomas: Subserosal tumors can extend out on attenuated stalks, detach, and become attached to surrounding pelvic organs to develop a new blood supply.
- Microscopic Morphology: Characterized by intersecting bundles of uniform, elongated smooth muscle cells with fibrillary acidophilic cytoplasm, mimicking the appearance of normal myometrium.
Because these tumors can grow rapidly, they often outgrow their blood supply, leading to degenerative changes (detectable in about 65% of cases). These include foci of fibrosis, softening, and:
- Hyaline degeneration: The most common (63%), replacing muscle with glassy, acellular tissue.
- Myxoid changes: (19%), making the tissue gelatinous.
- Calcification: (8%), particularly in older or postmenopausal women, creating hard, stone-like masses.
- Cystic changes: (4%).
- Fatty metamorphosis: (3%).
References & Further Reading
- Kumar, V., Abbas, A. K., & Aster, J. C. (2021). Robbins & Cotran Pathologic Basis of Disease (10th ed.). Elsevier. (Definitive guide on Endometrioid vs. Serous Carcinoma pathogenesis and Endometriosis theories).
- Crum, C. P., et al. (2018). Gynecologic and Obstetric Pathology. Elsevier. (Detailed microscopic morphology of AUB, hyperplasia, and polyps).
- Longo, D. L., et al. (2015). Harrison's Principles of Internal Medicine (19th ed.). McGraw-Hill Education. (Endocrine origins of anovulation and dysfunctional uterine bleeding).
Quick Quiz
Pathology of the Female Genital Tract Quiz
Pathology - mobile-friendly and focused practice.
Privacy: Your details are used only for quiz tracking and certificates.
Pathology of the Female Genital Tract Quiz
Pathology
Preparing questions...
Choose your answer and keep your streak alive.
Great effort.
Here is your quick performance summary.